ReNeuron aiming to take second stem cell therapy into clinic – PMLiVE
|
ReNeuron aiming to take second stem cell therapy into clinic
PMLiVE ReNeuron is already conducting trials of a neural stem cell product called CTX in stroke (phase II) and critical limb ischaemia (phase I). Taking a second stem cell type into the clinic – in what will be its first trial in the US – is a major milestone … |
